{"gene":"APEX1","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":1994,"finding":"The redox and DNA repair activities of APE1/Ref-1 are encoded by distinct, non-overlapping domains: the N-terminal domain (not conserved in other organisms) is required for redox activity, while conserved C-terminal sequences are required for DNA repair activity. Chemical alkylation or oxidation of cysteine sulfhydryls inhibits redox activity without affecting DNA repair activity. Crosslinking studies suggest a direct cysteine-mediated interaction between Ref-1 and Jun.","method":"Deletion mutagenesis, chemical alkylation/oxidation of cysteines, crosslinking assays, in vitro functional assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with deletion mutants and chemical mutagenesis, multiple orthogonal methods, widely replicated finding","pmids":["7506414"],"is_preprint":false},{"year":1997,"finding":"APE1/Ref-1 is a potent activator of p53 DNA-binding activity, acting by both redox-dependent and redox-independent mechanisms. Purified Ref-1 from HeLa nuclear extracts stimulates DNA binding by latent, oxidized p53. In the presence of reducing agent, Ref-1 stimulates full-length p53 but not the C-terminally truncated p53Δ30, indicating a redox-independent mechanism requiring the p53 C-terminus. Ref-1 also stimulates p53 transactivation in vivo.","method":"Protein purification from HeLa nuclear extracts, in vitro DNA-binding assays, in vivo transactivation assays, oxidized p53 stimulation assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical reconstitution with purified protein, multiple orthogonal methods (in vitro and in vivo), replicated in subsequent work","pmids":["9119221"],"is_preprint":false},{"year":1998,"finding":"APE1/Ref-1 stimulates the DNA-binding activity of the Pax-8 paired domain in vitro and enhances Pax-8-dependent transcriptional activation of the thyroglobulin promoter in co-transfection experiments, with nuclear Ref-1 levels correlating with reduced (active) Pax-8 levels in thyroid cell nuclear extracts.","method":"In vitro DNA-binding assay, co-transfection/reporter gene assay, immunoreactivity analysis of nuclear extracts","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — in vitro and cell-based assays from single lab, two orthogonal methods","pmids":["9813166"],"is_preprint":false},{"year":1999,"finding":"Ref-1 associates physically with p53 in vivo and in vitro. Ref-1 overexpression enhances p53 transactivation of multiple target promoters (p21, cyclin G, Bax) and increases p53-induced apoptosis. Antisense-mediated downregulation of Ref-1 markedly reduces p53 induction of p21 mRNA/protein and p53 transactivation of p21 and Bax promoters.","method":"Co-immunoprecipitation (in vivo and in vitro), antisense knockdown, reporter gene assays, endogenous gene expression analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP in vivo and in vitro, antisense loss-of-function with defined phenotype, multiple target promoters tested","pmids":["10523305"],"is_preprint":false},{"year":2006,"finding":"ERp57 (a protein disulfide isomerase) interacts with APE1/Ref-1 in vivo (by immunoprecipitation in HepG2, M14, and Raji cells). Oxidative stress increases nuclear Ref-1 associated with ERp57. ERp57 reduced by the thioredoxin-reductase/thioredoxin system stimulates AP-1 binding to DNA, and cells overexpressing ERp57 are protected against H2O2-induced cell killing, demonstrating cooperative activity between ERp57 and Ref-1 in reductive activation of transcription factors.","method":"Co-immunoprecipitation in multiple cell lines, DNA-binding assay, overexpression with oxidative stress challenge","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP in three cell lines, functional assay for cooperative activity, single lab","pmids":["16962936"],"is_preprint":false},{"year":2007,"finding":"Both APE1 and APE2 function in immunoglobulin class switch recombination (CSR) in mice. Mice haploinsufficient for APE1 (and deficient in APE2) show reduced CSR and decreased double-strand breaks in switch regions, placing APE1 downstream of abasic site generation (by UNG) in the CSR pathway and demonstrating a novel in vivo function for APE1 in converting abasic sites to single-strand and double-strand breaks required for CSR.","method":"Genetic mouse models (haploinsufficiency, knockout), CSR assay, DSB measurement","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in vivo with defined mechanistic phenotype, epistasis placing APE1 in the CSR pathway","pmids":["18025127"],"is_preprint":false},{"year":2008,"finding":"APE1/Ref-1 regulates PTEN expression via Egr-1. Acetylation of APE1 enhances its binding to distinct trans-acting complexes involved in activation or repression of the PTEN promoter. The acetylated form is deacetylated by histone deacetylases in vivo. H2O2 and HDAC inhibitors increase APE1 acetylation and PTEN induction; this induction is absent in APE1-depleted cells. Acetylatable APE1 is required for PTEN gene activation.","method":"siRNA knockdown, overexpression, HDAC inhibitor treatment, promoter-reporter assay, co-immunoprecipitation","journal":"Free radical research","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple methods (KD, OE, inhibitors, reporter assays), single lab","pmids":["18324520"],"is_preprint":false},{"year":2009,"finding":"APE1 depletion by siRNA causes arrest of cell proliferation and apoptosis in human cell lines in culture, correlated with accumulation of unrepaired abasic DNA damage. All effects are reversed by expression of S. cerevisiae Apn1, which shares only the AP endonuclease repair function with Ape1, demonstrating that the essential cellular function of APE1 is its DNA repair (AP endonuclease) activity.","method":"RNA interference (siRNA), complementation with heterologous AP endonuclease (Apn1), cell proliferation and apoptosis assays, abasic site accumulation measurement","journal":"DNA repair","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic complementation with a repair-only enzyme identifies the essential activity, supported by biochemical readout of AP site accumulation","pmids":["16199212"],"is_preprint":false},{"year":2012,"finding":"STAT3 DNA-binding and transcriptional activity is directly regulated by the redox function of APE1/Ref-1. Pharmacological blockade of APE1/Ref-1 redox function with E3330 abrogates STAT3 DNA binding. A redox-specific APE1 mutant strategy and gene knockdown confirmed the redox-dependence of this regulation.","method":"Overexpression, redox-specific mutagenesis, siRNA knockdown, redox inhibitor (E3330) treatment, reporter gene/DNA-binding assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple orthogonal methods (mutagenesis, KD, small molecule), single lab","pmids":["23094050"],"is_preprint":false},{"year":2014,"finding":"APE1 has 3' RNA phosphatase and 3'-5' exoribonuclease activities that share the same active site as its DNA nuclease activities, as demonstrated by site-directed mutagenesis of active-site residues (H309N, H309S, D283N, N68A, D210N, Y171F, D308A, F266A, D70A) that abolish 3' RNA phosphatase activity. Several population variants including the common D148E variant show >80% reduction in 3' RNA phosphatase activity.","method":"In vitro RNA substrate assays, site-directed mutagenesis of active-site residues, functional characterization of population variants","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assay with systematic active-site mutagenesis, single lab but rigorous biochemical approach","pmids":["25498387"],"is_preprint":false},{"year":2014,"finding":"APE1/Ref-1 redox function negatively regulates NRF2: repression of Ref-1 (by genetic or small molecule inhibitor approaches) potently activates NRF2 and its downstream targets in a dose-dependent fashion. This effect requires the redox function, not the DNA repair function, of APE1, and does not involve reactive oxygen species.","method":"siRNA/shRNA knockdown, small molecule inhibitor (E3330), NRF2 reporter/target gene assays, genetic and pharmacological dissection of redox vs. repair functions","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic and pharmacological methods to separate redox from repair function, single lab","pmids":["25492865"],"is_preprint":false},{"year":2015,"finding":"High-resolution crystal structures of human APE1 bound to DNA revealed: (1) the metal-binding site and nucleophile for AP-site incision; (2) arginine clamps that mediate product release; and (3) that a T-G mismatch 5' to the AP site is molded into a Watson-Crick-like geometry that distorts the active site and reduces incision efficiency, providing the molecular basis for clustered lesion processing.","method":"X-ray crystallography (multiple high-resolution APE1-DNA complex structures), kinetic/activity assays","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structures with multiple snapshots, functionally validated by activity assays","pmids":["26458045"],"is_preprint":false},{"year":2016,"finding":"Endogenous APE1 protects against ischemic infarction in both gray and white matter. Conditional knockout of Apex1 in mice dramatically enlarges infarct volume, increases AP sites, and activates prodeath signaling (PUMA and PARP1) after focal cerebral ischemia. APE1 cKO also worsens demyelination and axonal conduction, demonstrating a role for endogenous APE1 in neurological recovery after stroke.","method":"Conditional knockout mouse (tamoxifen-inducible Cre), focal cerebral ischemia model, AP site measurement, γ-H2AX/PUMA/PARP1 signaling, behavioral/electrophysiological readouts","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — first conditional knockout mouse for APE1 with multiple molecular and functional readouts in vivo","pmids":["27274063"],"is_preprint":false},{"year":2016,"finding":"APE1 variants D283G, L104R, and R237C have reduced AP endonuclease activity and impaired ability to associate with XRCC1 and DNA polymerase β (downstream BER partners), leading to persistent H2AX phosphorylation, elevated PAR protein levels, and growth defects through combined apoptotic and autophagic processes even without exogenous stress.","method":"shRNA silencing with variant complementation, Co-immunoprecipitation with XRCC1 and Pol β, γ-H2AX and PAR assays, cell growth analysis","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP for partner interactions, complementation assay, multiple molecular readouts, single lab","pmids":["27050370"],"is_preprint":false},{"year":2017,"finding":"APE1 facilitates BRCA1-mediated homologous recombination (HR) repair while counteracting error-prone non-homologous end joining of DNA double-strand breaks. APE1, coordinated with checkpoint kinase Chk2, regulates drug response of glioblastoma cells, and suppression of APE1/Chk2 signaling facilitates alternative HR protein recruitment.","method":"APE1 knockdown/overexpression, HR and NHEJ reporter assays, co-immunoprecipitation with Chk2 and HR proteins, glioblastoma cell drug response assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — functional reporter assays for HR/NHEJ choice, single lab with multiple methods","pmids":["28852018"],"is_preprint":false},{"year":2018,"finding":"High-resolution APE1-DNA crystal structures with 3' mismatches and DNA damage reveal that APE1 removes 3' mismatches and 3' damage by placing the 3' group within the intra-helical DNA cavity via a non-base-flipping mechanism. This process is facilitated by a DNA nick, instability of the mismatched/damaged base, and DNA bending by APE1.","method":"X-ray crystallography (multiple high-resolution APE1-DNA structural snapshots with mismatches/damage), biochemical activity assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple high-resolution crystal structures with functional validation, rigorous structural and biochemical analysis","pmids":["29374164"],"is_preprint":false},{"year":2018,"finding":"APE1 deficiency (via shRNA in primary human fibroblasts) induces cellular senescence associated with global DNA damage accumulation, induction of p16INK4a and p21WAF1, and pronounced DNA damage response (γ-H2AX) particularly at telomeres. Conditional Apex1 knockout in post-natal mice causes impaired growth, reduced organ size, increased cellular senescence, and premature aging features. Telomerase expression prevents the senescence phenotype.","method":"shRNA knockdown in primary fibroblasts and telomerase-expressing cells, conditional knockout mouse, γ-H2AX/p16/p21 assays, telomere FISH","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — both cell-based and in vivo conditional KO with multiple molecular readouts, mechanistic dissection via telomerase rescue","pmids":["29750271"],"is_preprint":false},{"year":2020,"finding":"APE1 senses DNA single-strand breaks (SSBs) and initiates 3'-5' SSB end resection via its exonuclease activity. APE1's exonuclease activity is critical for both SSB repair and SSB signaling in Xenopus egg extracts and in vitro reconstitution. APE1 interacts with APE2 and PCNA (though PCNA is dispensable for APE1 exonuclease activity). An APE1 exonuclease-deficient mutant identified in cancer tissue lacks this SSB repair function.","method":"Xenopus egg extract system, in vitro reconstitution, exonuclease mutant analysis, Co-IP of APE1 with APE2 and PCNA","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro reconstitution and Xenopus system, mutagenesis, but single lab","pmids":["31828326"],"is_preprint":false},{"year":2021,"finding":"APE1 distinguishes DNA substrates in exonucleolytic cleavage by an induced space-filling mechanism. Binding dsDNA induces an RM (Arg176 and Met269) bridge that defines a long and narrow product pocket, providing substrate selectivity based on hydrophobicity and steric hindrance rather than base identity. Crystal structures of APE1-dsDNA complexes displaying end-binding were determined, and both endonucleolytic and exonucleolytic cleavage are explained by this induced space-filling model.","method":"X-ray crystallography of APE1-dsDNA end-binding complexes, enzymatic activity assays, binding affinity measurements for varied substrates","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures plus enzymatic and binding assays, mechanistic model validated with multiple substrates, single lab","pmids":["33504804"],"is_preprint":false},{"year":2021,"finding":"Mitochondrial APE1 degrades dysfunctional (abasic) mitochondrial mRNA via endoribonuclease activity. Loss of APE1 results in accumulation of damaged mitochondrial mRNA, impaired mitochondrial protein translation, reduced expression of mitochondrial-encoded proteins, and less efficient mitochondrial respiration (oxidative phosphorylation).","method":"APE1 knockdown/depletion, mitochondrial mRNA association assays, endoribonuclease activity on abasic RNA, mitochondrial respiration (Seahorse), protein translation assays","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (RNA assay, respiration, translation), single lab","pmids":["34224750"],"is_preprint":false},{"year":2021,"finding":"Oscillatory shear stress promotes acetylation of APE1 by acetyltransferase p300, leading to APE1 nuclear translocation. Nuclear APE1 promotes inflammation by orchestrating the NF-κB pathway. Endothelial-specific deletion of APEX1 ameliorates atherogenesis in a partial ligation mouse model, and overexpression of APEX1 negates the anti-inflammatory effect of vitexin.","method":"Co-immunoprecipitation of p300 with APEX1, siRNA knockdown, endothelial-specific APEX1 deletion (mouse), overexpression, NF-κB pathway analysis, carotid partial ligation model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo endothelial-specific KO, Co-IP for p300 interaction, multiple functional readouts, single lab","pmids":["34810252"],"is_preprint":false},{"year":2022,"finding":"APE1 assembles biomolecular condensates via its extreme N-terminal motif in nucleoli, recruits ATR and its activators TopBP1 and ETAA1, and directly activates ATR to phosphorylate Chk1 in vitro. This activity is independent of APE1 nuclease and redox functions. A W119R mutant is deficient in nucleolar condensation and cannot activate the nucleolar ATR DDR pathway or ATR kinase in vitro.","method":"APE1 overexpression/knockdown, biomolecular condensate assays in vitro and in cells, in vitro ATR kinase assay, nucleolar co-localization with NPM1, Co-IP with ATR/TopBP1/ETAA1, W119R mutagenesis","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay, mutagenesis, condensate assays, Co-IP; single lab but multiple orthogonal methods","pmids":["36200829"],"is_preprint":false},{"year":2022,"finding":"APE1 cleaves solvent-exposed AP sites in nucleosomes with 3–6 orders of magnitude higher efficiency than occluded AP sites. A cryo-EM structure of APE1 bound to a nucleosome containing a solvent-exposed AP site reveals that APE1 uses a DNA sculpting mechanism, bending the nucleosomal DNA to access the AP site. Occluded AP sites are blocked by contacts between nucleosomal DNA and the histone octamer.","method":"Cryo-electron microscopy (APE1-nucleosome complex), kinetic AP site cleavage assays, biochemical analysis of nucleosomal substrates","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure combined with kinetic assays and biochemical characterization, rigorous mechanistic analysis","pmids":["36104361"],"is_preprint":false},{"year":2016,"finding":"Secreted APE1/Ref-1, whose secretion is triggered by acetylation, inhibits TNF-α binding to TNFR1 by inducing a conformational change (thiol-disulfide exchange) in the TNF receptor 1. Recombinant APE1/Ref-1 with reducing activity induced conformational change in rh-TNFR1, and neutralizing anti-APE1 antibody reversed the anti-inflammatory effect, recovering ROS generation and VCAM-1 upregulation.","method":"Recombinant protein treatment, anti-APE1 neutralizing antibody, thiol-disulfide exchange assay with rh-TNFR1, VCAM-1/ROS measurement","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — biochemical interaction assay between APE1 and TNFR1, functional antibody neutralization, single lab","pmids":["26964514"],"is_preprint":false},{"year":2013,"finding":"APE1 redox activity prevents oxidative inactivation of ERK2, forming a direct complex with ERK2 and rescuing ERK kinase activity from ROS-induced inactivation. This effect is dependent on Cys65-mediated redox activity and facilitates Cyclin D1 expression and G1-to-S cell cycle progression after lead acetate exposure.","method":"Co-immunoprecipitation of APE1 with ERK2, siRNA knockdown, redox inhibitor (E3330), forced APE1 overexpression, ERK activity assays, cell cycle analysis","journal":"Toxicology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, KD, and inhibitor approaches with defined mechanistic readout; single lab","pmids":["23370007"],"is_preprint":false},{"year":2024,"finding":"Conditional deletion of Apex1 in T cells results in accumulation of abasic DNA sites in proliferating T cells, genomic instability, and apoptotic death, preventing acquisition of T effector features. Mutational analyses pinpointed the endonuclease domain as essential for T effector cell generation. Chemical inhibition of APE1 base repair activity similarly abrogated autoimmune disease induction in mouse models.","method":"Conditional knockout of Apex1 in T cells, mutational analysis of endonuclease domain, chemical inhibitors, autoimmune disease mouse models, abasic site quantification, apoptosis assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with domain-specific mutational dissection and pharmacological confirmation, multiple in vivo readouts","pmids":["39739423"],"is_preprint":false},{"year":2024,"finding":"APE1 inhibition promotes ferroptosis in hepatocellular carcinoma by activating AKT oxidation, impairing AKT phosphorylation/activation, which leads to GSK3β dephosphorylation/activation and ubiquitin-proteasome-dependent NRF2 degradation, thereby suppressing SLC7A11 and GPX4 expression and triggering lipid peroxidation. This pathway requires the redox activity of APE1.","method":"Genetic and chemical inhibition of APE1, AKT oxidation assay, GSK3β phosphorylation, NRF2 ubiquitination/degradation assay, SLC7A11/GPX4 expression, lipid peroxidation measurement","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical pathway assays, genetic and pharmacological methods, single lab","pmids":["38418695"],"is_preprint":false},{"year":2022,"finding":"APE1 controls DICER1 expression in non-small-cell lung cancer via regulation of miR-33a-5p and miR-130b-3p. DICER1 is validated as a direct functional target of APE1-regulated miRNAs, and IHC analyses confirmed a negative correlation between APE1 and DICER1 protein levels in human tumors.","method":"siRNA-mediated APE1 depletion, high-throughput miRNA profiling, miRNA target validation (DICER1 as target of miR-33a-5p and miR-130b-3p), IHC on human tumor tissue","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — functional target validation with knockdown and miRNA assays, IHC confirmation in human tissue, single lab","pmids":["35876890"],"is_preprint":false},{"year":2014,"finding":"Mitochondrial APE1/Ref-1 suppresses PKC-induced mitochondrial dysfunction (hyperpolarization and ROS generation) in mouse endothelial cells. PMA-induced PKC activation increases mitochondrial translocation of APE1/Ref-1, and a mitochondrial targeting sequence-fused APE1 more effectively suppresses mitochondrial dysfunction than wild-type APE1.","method":"PKC activator (PMA) treatment, APE1 overexpression and gene silencing, MTS-fused APE1 construct, mitochondrial membrane potential and ROS assays","journal":"Mitochondrion","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — overexpression/KD with functional readout, MTS fusion construct for compartment-specific rescue, single lab","pmids":["24861944"],"is_preprint":false},{"year":2021,"finding":"APE1 inhibits pyroptosis in lung adenocarcinoma cells by inactivating the STING pathway via direct interaction with AIM2 and DDX41 (as detected by co-immunoprecipitation). This interaction prevents STING pathway activation, contributing to radiation resistance.","method":"RNA-seq, co-immunoprecipitation (APE1 with AIM2 and DDX41), APE1 knockdown/overexpression, pyroptosis and STING pathway assays, radiation resistance assays","journal":"Translational oncology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP is single method, mechanistic link to STING inactivation via direct interaction established in one lab without independent validation","pmids":["37544034"],"is_preprint":false}],"current_model":"APE1/Ref-1 is a multifunctional enzyme whose C-terminal domain performs essential AP endonuclease activity in base excision repair (cleaving the DNA backbone 5' to abasic sites via a metal-dependent mechanism with arginine clamps and a DNA-sculpting mechanism that also operates in the nucleosome), while its N-terminal domain mediates redox-dependent reductive activation of multiple transcription factors (AP-1, p53, NF-κB, HIF-1α, STAT3, Pax-8 and others) through a cysteine-mediated mechanism; additional activities include 3'-5' exonuclease and 3' RNA phosphatase/exoribonuclease functions sharing the same catalytic active site, initiation of SSB end resection, participation in immunoglobulin class switch recombination, condensate-dependent activation of the ATR-Chk1 DDR pathway in nucleoli, and regulation of mitochondrial mRNA quality control, with the protein's subcellular localization and activity further modulated by post-translational modifications including acetylation (which drives nuclear translocation and secretion) and interactions with partners including p53, XRCC1, DNA polymerase β, ERK2, ERp57, and the p300 acetyltransferase."},"narrative":{"mechanistic_narrative":"APE1/Ref-1 is a multifunctional enzyme that couples DNA base excision repair (BER) to redox-dependent regulation of transcription, with its two activities encoded by separable domains: a non-conserved N-terminal domain mediates cysteine-dependent reductive activation of transcription factors, while conserved C-terminal sequences carry out DNA repair [PMID:7506414]. The DNA repair arm performs AP endonuclease incision 5' to abasic sites through a metal- and nucleophile-dependent mechanism, using arginine clamps for product release and molding mismatched bases into Watson-Crick-like geometry to discriminate clustered lesions [PMID:26458045]; the same active site also supports 3' mismatch/damage removal by a non-base-flipping, DNA-bending mechanism and exonucleolytic cleavage governed by an induced space-filling RM bridge [PMID:29374164, PMID:33504804], and operates on nucleosomal substrates by sculpting and bending DNA to reach solvent-exposed abasic sites [PMID:36104361]. This repair function is the essential cellular activity of APE1, as a repair-only heterologous AP endonuclease rescues the proliferation arrest and apoptosis caused by APE1 depletion [PMID:16199212], and it acts through BER partners XRCC1 and DNA polymerase β [PMID:27050370] while initiating SSB end resection via its exonuclease activity in concert with APE2 and PCNA [PMID:31828326]. In parallel, the redox function reductively activates transcription factors including p53, Pax-8, AP-1 and STAT3, with p53 stimulated by both redox-dependent and redox-independent mechanisms via direct physical association [PMID:9119221, PMID:10523305, PMID:23094050], and negatively regulates NRF2 independently of repair [PMID:25492865]. APE1 has additional RNA-directed roles, possessing 3' RNA phosphatase and 3'-5' exoribonuclease activities at its shared catalytic site [PMID:25498387] and degrading abasic mitochondrial mRNA to sustain mitochondrial translation and respiration [PMID:34224750]. Beyond catalysis, an extreme N-terminal motif drives nucleolar condensate assembly that recruits and activates the ATR-Chk1 DNA damage response independently of nuclease and redox functions [PMID:36200829]. APE1 localization and secretion are tuned by p300-mediated acetylation, which drives nuclear translocation and NF-κB-dependent inflammatory signaling [PMID:34810252]; in vivo, endogenous APE1 protects against ischemic brain injury [PMID:27274063], restrains cellular senescence and premature aging [PMID:29750271], and is required for T effector cell generation and class switch recombination [PMID:18025127, PMID:39739423].","teleology":[{"year":1994,"claim":"Established that APE1/Ref-1's redox and DNA repair activities are mechanistically and structurally separable, defining the gene as a bifunctional protein rather than a single-activity enzyme.","evidence":"Deletion mutagenesis, cysteine alkylation/oxidation, and crosslinking in vitro","pmids":["7506414"],"confidence":"High","gaps":["Did not resolve atomic basis of either activity","Cysteine identity mediating redox activity not pinpointed"]},{"year":1997,"claim":"Showed APE1/Ref-1 activates p53 by both redox-dependent and redox-independent routes, broadening its transcriptional regulatory scope beyond simple cysteine reduction.","evidence":"Purified Ref-1 with in vitro DNA-binding and in vivo transactivation assays","pmids":["9119221"],"confidence":"High","gaps":["Structural basis of redox-independent p53 stimulation not defined","Physiological stimulus context unaddressed"]},{"year":1999,"claim":"Demonstrated a direct physical APE1-p53 interaction that is functionally required for p53 transactivation of target genes and apoptosis, linking redox regulation to a defined transcriptional program.","evidence":"Reciprocal Co-IP and antisense knockdown with promoter-reporter and endogenous gene readouts","pmids":["10523305"],"confidence":"High","gaps":["Interaction interface not mapped","Did not separate repair from redox contribution to p53 effects"]},{"year":1998,"claim":"Extended the redox-coactivator role to Pax-8, showing APE1/Ref-1 reductively activates a tissue-specific transcription factor.","evidence":"In vitro DNA-binding and co-transfection reporter assays in thyroid cells","pmids":["9813166"],"confidence":"Medium","gaps":["Single-lab cell-based evidence","Direct interaction not demonstrated by reciprocal methods"]},{"year":2006,"claim":"Identified ERp57 as an APE1 partner and component of a reductive activation system, providing a source of reducing equivalents for transcription factor activation under oxidative stress.","evidence":"Co-IP in three cell lines plus DNA-binding and oxidative-stress survival assays","pmids":["16962936"],"confidence":"Medium","gaps":["Single lab","Stoichiometry and direct electron-transfer mechanism unresolved"]},{"year":2009,"claim":"Resolved which APE1 activity is essential by complementation, proving the AP endonuclease repair function—not redox—is required for cell viability.","evidence":"siRNA depletion rescued by repair-only S. cerevisiae Apn1, with abasic site quantification","pmids":["16199212"],"confidence":"High","gaps":["Does not address non-essential but physiologically important redox/RNA roles","Cell-line context only"]},{"year":2014,"claim":"Revealed that APE1's DNA nuclease active site also performs 3' RNA phosphatase and exoribonuclease chemistry, and that common population variants impair this RNA activity.","evidence":"In vitro RNA substrate assays with systematic active-site mutagenesis and variant characterization","pmids":["25498387"],"confidence":"High","gaps":["Cellular RNA substrates not identified in this study","Functional consequence of variant RNA defects in vivo unknown"]},{"year":2014,"claim":"Defined a redox-specific role for APE1 in negatively regulating the NRF2 antioxidant program, cleanly separated from repair and independent of ROS.","evidence":"Genetic and small-molecule (E3330) repression with NRF2 reporter/target assays","pmids":["25492865"],"confidence":"Medium","gaps":["Direct molecular target of redox action on NRF2 pathway not identified","Single lab"]},{"year":2012,"claim":"Added STAT3 to the set of transcription factors whose DNA binding requires APE1 redox function, reinforcing redox control of oncogenic signaling.","evidence":"Redox-specific mutagenesis, knockdown, and E3330 inhibition with DNA-binding/reporter assays","pmids":["23094050"],"confidence":"Medium","gaps":["Direct STAT3-APE1 contact not structurally defined","Single lab"]},{"year":2015,"claim":"Provided the first high-resolution structural basis for AP-site incision, defining the metal/nucleophile site, arginine product-release clamps, and the mechanism of clustered lesion discrimination.","evidence":"Multiple X-ray structures of APE1-DNA complexes with kinetic validation","pmids":["26458045"],"confidence":"High","gaps":["Did not capture exonuclease or RNA substrate states","Nucleosomal context not addressed"]},{"year":2016,"claim":"Demonstrated an endogenous neuroprotective role for APE1 in vivo, linking its repair function to limiting AP-site accumulation and prodeath signaling after stroke.","evidence":"Tamoxifen-inducible conditional Apex1 knockout in a focal cerebral ischemia model","pmids":["27274063"],"confidence":"High","gaps":["Did not isolate repair vs redox contributions to neuroprotection","Cell-type-specific source of protection not fully resolved"]},{"year":2016,"claim":"Connected disease-associated APE1 variants to defective partner engagement, showing reduced AP endonuclease activity and impaired XRCC1/Pol β association drive genomic stress and growth defects.","evidence":"shRNA-variant complementation with Co-IP and γH2AX/PAR readouts","pmids":["27050370"],"confidence":"Medium","gaps":["Whether interaction loss is cause or consequence of activity loss unclear","Single lab"]},{"year":2017,"claim":"Implicated APE1 in double-strand break repair pathway choice, favoring BRCA1-mediated HR over error-prone NHEJ and influencing chemoresistance.","evidence":"Knockdown/overexpression with HR/NHEJ reporters and Co-IP with Chk2 and HR proteins","pmids":["28852018"],"confidence":"Medium","gaps":["Mechanism by which APE1 biases pathway choice not defined","Single lab"]},{"year":2018,"claim":"Defined the structural mechanism for 3' mismatch/damage removal, showing APE1 places the 3' group intra-helically without base flipping, aided by DNA nicks and bending.","evidence":"Multiple high-resolution APE1-DNA crystal structures with biochemical assays","pmids":["29374164"],"confidence":"High","gaps":["Cellular pathway recruiting this proofreading activity not established","Single lab"]},{"year":2018,"claim":"Established APE1 as a guardian against senescence and aging, with deficiency causing telomere-associated DNA damage and premature aging features rescuable by telomerase.","evidence":"shRNA in primary fibroblasts plus conditional Apex1 knockout mice with telomere FISH","pmids":["29750271"],"confidence":"High","gaps":["Mechanistic link between APE1 loss and telomere-specific damage incomplete","Repair vs other activities not dissected"]},{"year":2020,"claim":"Showed APE1 senses single-strand breaks and initiates 3'-5' end resection via its exonuclease activity, defining a role in SSB repair and signaling beyond simple incision.","evidence":"Xenopus egg extract and in vitro reconstitution with exonuclease mutant and Co-IP of APE2/PCNA","pmids":["31828326"],"confidence":"Medium","gaps":["Relative contribution of APE1 vs APE2 resection in human cells unclear","Single lab"]},{"year":2021,"claim":"Provided a unifying structural model—an induced RM space-filling bridge—explaining how APE1 selects substrates for both endonucleolytic and exonucleolytic cleavage by sterics rather than base identity.","evidence":"X-ray structures of APE1-dsDNA end-binding complexes with activity and binding assays","pmids":["33504804"],"confidence":"High","gaps":["Single lab","In-cell relevance of end-binding mode not tested"]},{"year":2021,"claim":"Uncovered a mitochondrial RNA surveillance function, showing APE1 degrades abasic mitochondrial mRNA to maintain mitochondrial translation and respiration.","evidence":"APE1 depletion with endoribonuclease assays, Seahorse respiration, and translation readouts","pmids":["34224750"],"confidence":"Medium","gaps":["Full set of mitochondrial RNA substrates not catalogued","Single lab"]},{"year":2021,"claim":"Revealed a non-catalytic scaffolding function: APE1 forms nucleolar condensates that recruit and directly activate the ATR-Chk1 DDR pathway, independent of nuclease and redox activities.","evidence":"Condensate assays, in vitro ATR kinase assay, Co-IP with ATR/TopBP1/ETAA1, and W119R mutagenesis","pmids":["36200829"],"confidence":"Medium","gaps":["Physiological trigger for nucleolar condensation unclear","Single lab"]},{"year":2022,"claim":"Extended AP-site incision to chromatin, showing APE1 cleaves solvent-exposed nucleosomal abasic sites via a DNA-sculpting/bending mechanism while occluded sites are protected.","evidence":"Cryo-EM of an APE1-nucleosome complex with kinetic cleavage assays","pmids":["36104361"],"confidence":"High","gaps":["How occluded sites are eventually repaired not resolved","Role of chromatin remodelers not addressed"]},{"year":2021,"claim":"Linked acetylation-controlled APE1 trafficking to vascular inflammation, with p300-driven acetylation promoting nuclear translocation and NF-κB-dependent atherogenesis.","evidence":"Co-IP of p300/APEX1, endothelial-specific Apex1 deletion in a partial ligation mouse model","pmids":["34810252"],"confidence":"Medium","gaps":["Acetylated residues and NF-κB engagement mechanism not fully mapped","Single lab"]},{"year":2024,"claim":"Demonstrated the endonuclease repair function is required in vivo for adaptive immunity, with T-cell Apex1 loss causing abasic-site accumulation, genomic instability, and failed T effector generation.","evidence":"Conditional T-cell Apex1 knockout with domain-specific mutagenesis and chemical inhibition in autoimmune models","pmids":["39739423"],"confidence":"High","gaps":["Redox-domain contribution to T-cell function not isolated","Substrate context driving the requirement not detailed"]},{"year":null,"claim":"How APE1's multiple activities—repair, redox, RNA processing, and condensate scaffolding—are coordinately partitioned across nucleus, nucleolus, mitochondria, and the secreted pool in a single cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking PTM state to activity selection","Quantitative partitioning between compartments unknown","Crosstalk between redox and repair functions in vivo undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[7,11,15,18,22]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[9,19]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[11,15,18,17]},{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,24]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,3,8]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[11,15,18]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[9,19]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,3,20]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[21]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[19,28]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[23]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[7,11,13,17]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,3,8]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[10,26]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[5,25]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[21,24]}],"complexes":[],"partners":["TP53","XRCC1","POLB","APEX2","PCNA","EP300","MAPK1","PDIA3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P27695","full_name":"DNA repair nuclease/redox regulator APEX1","aliases":["APEX nuclease","APEN","Apurinic-apyrimidinic endonuclease 1","AP endonuclease 1","APE-1","DNA-(apurinic or apyrimidinic site) endonuclease","Redox factor-1","REF-1"],"length_aa":318,"mass_kda":35.6,"function":"Multifunctional protein that plays a central role in the cellular response to oxidative stress. The two major activities of APEX1 are DNA repair and redox regulation of transcriptional factors (PubMed:11118054, PubMed:11452037, PubMed:15831793, PubMed:18439621, PubMed:18579163, PubMed:21762700, PubMed:24079850, PubMed:8355688, PubMed:9108029, PubMed:9560228). Functions as an apurinic/apyrimidinic (AP) endodeoxyribonuclease in the base excision repair (BER) pathway of DNA lesions induced by oxidative and alkylating agents. Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. Also incises at AP sites in the DNA strand of DNA/RNA hybrids, single-stranded DNA regions of R-loop structures, and single-stranded RNA molecules (PubMed:15380100, PubMed:16617147, PubMed:18439621, PubMed:19123919, PubMed:19188445, PubMed:19934257, PubMed:20699270, PubMed:21762700, PubMed:24079850, PubMed:8932375, PubMed:8995436, PubMed:9804799). Operates at switch sites of immunoglobulin (Ig) constant regions where it mediates Ig isotype class switch recombination. Processes AP sites induced by successive action of AICDA and UNG. Generates staggered nicks in opposite DNA strands resulting in the formation of double-strand DNA breaks that are finally resolved via non-homologous end joining repair pathway (By similarity). Has 3'-5' exodeoxyribonuclease activity on mismatched deoxyribonucleotides at the 3' termini of nicked or gapped DNA molecules during short-patch BER (PubMed:11832948, PubMed:1719477). Possesses DNA 3' phosphodiesterase activity capable of removing lesions (such as phosphoglycolate and 8-oxoguanine) blocking the 3' side of DNA strand breaks (PubMed:15831793, PubMed:7516064). Also acts as an endoribonuclease involved in the control of single-stranded RNA metabolism. Plays a role in regulating MYC mRNA turnover by preferentially cleaving in between UA and CA dinucleotides of the MYC coding region determinant (CRD). In association with NMD1, plays a role in the rRNA quality control process during cell cycle progression (PubMed:19188445, PubMed:19401441, PubMed:21762700). Acts as a loading factor for POLB onto non-incised AP sites in DNA and stimulates the 5'-terminal deoxyribose 5'-phosphate (dRp) excision activity of POLB (PubMed:9207062). Exerts reversible nuclear redox activity to regulate DNA binding affinity and transcriptional activity of transcriptional factors by controlling the redox status of their DNA-binding domain, such as the FOS/JUN AP-1 complex after exposure to IR (PubMed:10023679, PubMed:11118054, PubMed:11452037, PubMed:18579163, PubMed:8355688, PubMed:9108029). Involved in calcium-dependent down-regulation of parathyroid hormone (PTH) expression by binding to negative calcium response elements (nCaREs). Together with HNRNPL or the dimer XRCC5/XRCC6, associates with nCaRE, acting as an activator of transcriptional repression (PubMed:11809897, PubMed:14633989, PubMed:8621488). May also play a role in the epigenetic regulation of gene expression by participating in DNA demethylation (PubMed:21496894). Stimulates the YBX1-mediated MDR1 promoter activity, when acetylated at Lys-6 and Lys-7, leading to drug resistance (PubMed:18809583). Plays a role in protection from granzyme-mediated cellular repair leading to cell death (PubMed:18179823). Binds DNA and RNA. Associates, together with YBX1, on the MDR1 promoter. Together with NPM1, associates with rRNA (PubMed:19188445, PubMed:19401441, PubMed:20699270)","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/P27695/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/APEX1","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SCAMP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/APEX1","total_profiled":1310},"omim":[{"mim_id":"609413","title":"ERCC EXCISION REPAIR 6, CHROMATIN REMODELING FACTOR; ERCC6","url":"https://www.omim.org/entry/609413"},{"mim_id":"607790","title":"TET METHYLCYTOSINE DIOXYGENASE 1; TET1","url":"https://www.omim.org/entry/607790"},{"mim_id":"606350","title":"APRATAXIN; APTX","url":"https://www.omim.org/entry/606350"},{"mim_id":"603780","title":"RECQ PROTEIN-LIKE 4; RECQL4","url":"https://www.omim.org/entry/603780"},{"mim_id":"300773","title":"APEX NUCLEASE (APURINIC/APYRIMIDINIC ENDONUCLEASE) 2; APEX2","url":"https://www.omim.org/entry/300773"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Centrosome","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/APEX1"},"hgnc":{"alias_symbol":["APE","REF1","HAP1","APX","APEN","REF-1","APE-1","APE1"],"prev_symbol":["APEX"]},"alphafold":{"accession":"P27695","domains":[{"cath_id":"3.60.10.10","chopping":"61-315","consensus_level":"medium","plddt":97.5087,"start":61,"end":315}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P27695","model_url":"https://alphafold.ebi.ac.uk/files/AF-P27695-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P27695-F1-predicted_aligned_error_v6.png","plddt_mean":90.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=APEX1","jax_strain_url":"https://www.jax.org/strain/search?query=APEX1"},"sequence":{"accession":"P27695","fasta_url":"https://rest.uniprot.org/uniprotkb/P27695.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P27695/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P27695"}},"corpus_meta":[{"pmid":"11018583","id":"PMC_11018583","title":"Going APE over ref-1.","date":"2000","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/11018583","citation_count":478,"is_preprint":false},{"pmid":"9119221","id":"PMC_9119221","title":"Identification of redox/repair protein Ref-1 as a potent activator of p53.","date":"1997","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9119221","citation_count":423,"is_preprint":false},{"pmid":"18976116","id":"PMC_18976116","title":"The many functions of APE1/Ref-1: not only a DNA repair enzyme.","date":"2009","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/18976116","citation_count":417,"is_preprint":false},{"pmid":"7506414","id":"PMC_7506414","title":"The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7506414","citation_count":326,"is_preprint":false},{"pmid":"15706084","id":"PMC_15706084","title":"The intracellular localization of APE1/Ref-1: more than a passive phenomenon?","date":"2005","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/15706084","citation_count":324,"is_preprint":false},{"pmid":"17560642","id":"PMC_17560642","title":"The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.","date":"2007","source":"Molecular aspects of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17560642","citation_count":226,"is_preprint":false},{"pmid":"18715144","id":"PMC_18715144","title":"Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein.","date":"2009","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/18715144","citation_count":216,"is_preprint":false},{"pmid":"10523305","id":"PMC_10523305","title":"Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10523305","citation_count":201,"is_preprint":false},{"pmid":"16199212","id":"PMC_16199212","title":"Molecular and biological roles of Ape1 protein in mammalian base excision repair.","date":"2005","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/16199212","citation_count":181,"is_preprint":false},{"pmid":"20056333","id":"PMC_20056333","title":"Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer.","date":"2010","source":"Cancer treatment reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20056333","citation_count":180,"is_preprint":false},{"pmid":"22122463","id":"PMC_22122463","title":"APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.","date":"2012","source":"Current molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22122463","citation_count":141,"is_preprint":false},{"pmid":"26458045","id":"PMC_26458045","title":"Capturing snapshots of APE1 processing DNA damage.","date":"2015","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26458045","citation_count":141,"is_preprint":false},{"pmid":"25033834","id":"PMC_25033834","title":"APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions.","date":"2014","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25033834","citation_count":136,"is_preprint":false},{"pmid":"18025127","id":"PMC_18025127","title":"APE1- and APE2-dependent DNA breaks in immunoglobulin class switch recombination.","date":"2007","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18025127","citation_count":129,"is_preprint":false},{"pmid":"28825044","id":"PMC_28825044","title":"Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.","date":"2017","source":"NPJ precision oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28825044","citation_count":123,"is_preprint":false},{"pmid":"30170830","id":"PMC_30170830","title":"APE1: A skilled nucleic acid surgeon.","date":"2018","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/30170830","citation_count":122,"is_preprint":false},{"pmid":"21700832","id":"PMC_21700832","title":"Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.","date":"2011","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21700832","citation_count":100,"is_preprint":false},{"pmid":"29374164","id":"PMC_29374164","title":"Molecular snapshots of APE1 proofreading mismatches and removing DNA damage.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29374164","citation_count":90,"is_preprint":false},{"pmid":"23094050","id":"PMC_23094050","title":"APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23094050","citation_count":90,"is_preprint":false},{"pmid":"19180539","id":"PMC_19180539","title":"Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells.","date":"2009","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/19180539","citation_count":86,"is_preprint":false},{"pmid":"18823566","id":"PMC_18823566","title":"Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population.","date":"2008","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/18823566","citation_count":84,"is_preprint":false},{"pmid":"9813166","id":"PMC_9813166","title":"Ref-1 controls pax-8 DNA-binding activity.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9813166","citation_count":80,"is_preprint":false},{"pmid":"23879289","id":"PMC_23879289","title":"Emerging roles of the nucleolus in regulating the DNA damage response: the noncanonical DNA repair enzyme APE1/Ref-1 as a paradigmatical example.","date":"2013","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/23879289","citation_count":78,"is_preprint":false},{"pmid":"14599768","id":"PMC_14599768","title":"APE/Ref-1 and the mammalian response to genotoxic stress.","date":"2003","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/14599768","citation_count":76,"is_preprint":false},{"pmid":"20809131","id":"PMC_20809131","title":"Small molecule inhibitors of DNA repair nuclease activities of APE1.","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20809131","citation_count":76,"is_preprint":false},{"pmid":"16962936","id":"PMC_16962936","title":"Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors.","date":"2006","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16962936","citation_count":66,"is_preprint":false},{"pmid":"11084372","id":"PMC_11084372","title":"Human APE/Ref-1 protein.","date":"2000","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11084372","citation_count":63,"is_preprint":false},{"pmid":"25492865","id":"PMC_25492865","title":"Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25492865","citation_count":60,"is_preprint":false},{"pmid":"19492297","id":"PMC_19492297","title":"Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells.","date":"2009","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/19492297","citation_count":60,"is_preprint":false},{"pmid":"25672588","id":"PMC_25672588","title":"APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.","date":"2015","source":"Cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/25672588","citation_count":59,"is_preprint":false},{"pmid":"32146371","id":"PMC_32146371","title":"Revascularization and limb salvage following critical limb ischemia by nanoceria-induced Ref-1/APE1-dependent angiogenesis.","date":"2020","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/32146371","citation_count":59,"is_preprint":false},{"pmid":"27274063","id":"PMC_27274063","title":"APE1/Ref-1 facilitates recovery of gray and white matter and neurological function after mild stroke injury.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27274063","citation_count":55,"is_preprint":false},{"pmid":"35296074","id":"PMC_35296074","title":"APE1/Ref-1 Role in Inflammation and Immune Response.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35296074","citation_count":54,"is_preprint":false},{"pmid":"33504804","id":"PMC_33504804","title":"APE1 distinguishes DNA substrates in exonucleolytic cleavage by induced space-filling.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33504804","citation_count":54,"is_preprint":false},{"pmid":"29750271","id":"PMC_29750271","title":"APE1 deficiency promotes cellular senescence and premature aging features.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29750271","citation_count":54,"is_preprint":false},{"pmid":"26520369","id":"PMC_26520369","title":"APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.","date":"2015","source":"Mutation research. Genetic toxicology and environmental mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/26520369","citation_count":54,"is_preprint":false},{"pmid":"29122935","id":"PMC_29122935","title":"In vivo measurements of interindividual differences in DNA glycosylases and APE1 activities.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29122935","citation_count":53,"is_preprint":false},{"pmid":"38418695","id":"PMC_38418695","title":"APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/38418695","citation_count":51,"is_preprint":false},{"pmid":"18324520","id":"PMC_18324520","title":"APE1/Ref-1 regulates PTEN expression mediated by Egr-1.","date":"2008","source":"Free radical research","url":"https://pubmed.ncbi.nlm.nih.gov/18324520","citation_count":50,"is_preprint":false},{"pmid":"31828326","id":"PMC_31828326","title":"APE1 senses DNA single-strand breaks for repair and signaling.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31828326","citation_count":49,"is_preprint":false},{"pmid":"36104361","id":"PMC_36104361","title":"Structural basis for APE1 processing DNA damage in the nucleosome.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36104361","citation_count":46,"is_preprint":false},{"pmid":"28161249","id":"PMC_28161249","title":"Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).","date":"2017","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28161249","citation_count":45,"is_preprint":false},{"pmid":"34810252","id":"PMC_34810252","title":"Vitexin inhibits APEX1 to counteract the flow-induced endothelial inflammation.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34810252","citation_count":45,"is_preprint":false},{"pmid":"27057081","id":"PMC_27057081","title":"Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.","date":"2016","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/27057081","citation_count":44,"is_preprint":false},{"pmid":"30076264","id":"PMC_30076264","title":"Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.","date":"2018","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/30076264","citation_count":43,"is_preprint":false},{"pmid":"20218738","id":"PMC_20218738","title":"APEX1 gene amplification and its protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival.","date":"2010","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/20218738","citation_count":43,"is_preprint":false},{"pmid":"37508559","id":"PMC_37508559","title":"Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/37508559","citation_count":43,"is_preprint":false},{"pmid":"20711647","id":"PMC_20711647","title":"Posttranslational modification of mammalian AP endonuclease (APE1).","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20711647","citation_count":43,"is_preprint":false},{"pmid":"31024003","id":"PMC_31024003","title":"AP endonuclease 1 (Apex1) influences brain development linking oxidative stress and DNA repair.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31024003","citation_count":42,"is_preprint":false},{"pmid":"31816044","id":"PMC_31816044","title":"Functions of the major abasic endonuclease (APE1) in cell viability and genotoxin resistance.","date":"2020","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31816044","citation_count":42,"is_preprint":false},{"pmid":"7568229","id":"PMC_7568229","title":"APX-1 can substitute for its homolog LAG-2 to direct cell interactions throughout Caenorhabditis elegans development.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7568229","citation_count":41,"is_preprint":false},{"pmid":"27231670","id":"PMC_27231670","title":"Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein.","date":"2016","source":"Chonnam medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27231670","citation_count":40,"is_preprint":false},{"pmid":"36200829","id":"PMC_36200829","title":"APE1 assembles biomolecular condensates to promote the ATR-Chk1 DNA damage response in nucleolus.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36200829","citation_count":40,"is_preprint":false},{"pmid":"22122462","id":"PMC_22122462","title":"Small-molecule inhibitors of APE1 DNA repair function: an overview.","date":"2012","source":"Current molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22122462","citation_count":37,"is_preprint":false},{"pmid":"24944672","id":"PMC_24944672","title":"Aberrant expression of redox protein Ape1 in colon cancer stem cells.","date":"2014","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/24944672","citation_count":37,"is_preprint":false},{"pmid":"34557865","id":"PMC_34557865","title":"APE1/Ref-1 - One Target with Multiple Indications: Emerging Aspects and New Directions.","date":"2021","source":"Journal of cellular signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34557865","citation_count":35,"is_preprint":false},{"pmid":"31413178","id":"PMC_31413178","title":"Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.","date":"2019","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/31413178","citation_count":34,"is_preprint":false},{"pmid":"9406232","id":"PMC_9406232","title":"The structure and functions of the HAP1/Ref-1 protein.","date":"1997","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/9406232","citation_count":34,"is_preprint":false},{"pmid":"37725609","id":"PMC_37725609","title":"Development of a DNAzyme Walker for the Detection of APE1 in Living Cancer Cells.","date":"2023","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37725609","citation_count":34,"is_preprint":false},{"pmid":"26964514","id":"PMC_26964514","title":"Secreted APE1/Ref-1 inhibits TNF-α-stimulated endothelial inflammation via thiol-disulfide exchange in TNF receptor.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26964514","citation_count":33,"is_preprint":false},{"pmid":"16615870","id":"PMC_16615870","title":"A new standard nomenclature for proteins related to Apx and Shroom.","date":"2006","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16615870","citation_count":33,"is_preprint":false},{"pmid":"28852018","id":"PMC_28852018","title":"Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28852018","citation_count":32,"is_preprint":false},{"pmid":"36916696","id":"PMC_36916696","title":"Closed Cyclic DNA Machine for Sensitive Logic Operation and APE1 Detection.","date":"2023","source":"Small (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36916696","citation_count":31,"is_preprint":false},{"pmid":"20852942","id":"PMC_20852942","title":"Base excision repair genes XRCC1 and APEX1 and the risk for prostate cancer.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/20852942","citation_count":28,"is_preprint":false},{"pmid":"25498387","id":"PMC_25498387","title":"Human apurinic/apyrimidinic endonuclease 1 (APE1) has 3' RNA phosphatase and 3' exoribonuclease activities.","date":"2014","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25498387","citation_count":28,"is_preprint":false},{"pmid":"23776569","id":"PMC_23776569","title":"Functional assessment of population and tumor-associated APE1 protein variants.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23776569","citation_count":27,"is_preprint":false},{"pmid":"28946662","id":"PMC_28946662","title":"APE1/Ref-1 Inhibits Phosphate-Induced Calcification and Osteoblastic Phenotype Changes in Vascular Smooth Muscle Cells.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28946662","citation_count":26,"is_preprint":false},{"pmid":"27050370","id":"PMC_27050370","title":"APE1 polymorphic variants cause persistent genomic stress and affect cancer cell proliferation.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27050370","citation_count":26,"is_preprint":false},{"pmid":"38311014","id":"PMC_38311014","title":"New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.","date":"2024","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/38311014","citation_count":24,"is_preprint":false},{"pmid":"23408843","id":"PMC_23408843","title":"Genetic and expressional variations of APEX1 are associated with increased risk of head and neck cancer.","date":"2013","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23408843","citation_count":24,"is_preprint":false},{"pmid":"24970265","id":"PMC_24970265","title":"Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24970265","citation_count":24,"is_preprint":false},{"pmid":"38165468","id":"PMC_38165468","title":"The APE1/REF-1 and the hallmarks of cancer.","date":"2024","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/38165468","citation_count":23,"is_preprint":false},{"pmid":"23065211","id":"PMC_23065211","title":"Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.","date":"2012","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23065211","citation_count":22,"is_preprint":false},{"pmid":"34638620","id":"PMC_34638620","title":"Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34638620","citation_count":22,"is_preprint":false},{"pmid":"24893568","id":"PMC_24893568","title":"Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.","date":"2014","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24893568","citation_count":22,"is_preprint":false},{"pmid":"35136031","id":"PMC_35136031","title":"Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35136031","citation_count":22,"is_preprint":false},{"pmid":"35876890","id":"PMC_35876890","title":"APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/35876890","citation_count":21,"is_preprint":false},{"pmid":"34322687","id":"PMC_34322687","title":"APE1/Ref-1 as a Novel Target for Retinal Diseases.","date":"2021","source":"Journal of cellular signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34322687","citation_count":21,"is_preprint":false},{"pmid":"34224750","id":"PMC_34224750","title":"DNA Repair Protein APE1 Degrades Dysfunctional Abasic mRNA in Mitochondria Affecting Oxidative Phosphorylation.","date":"2021","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34224750","citation_count":21,"is_preprint":false},{"pmid":"25363495","id":"PMC_25363495","title":"5-HMF prevents against oxidative injury via APE/Ref-1.","date":"2014","source":"Free radical research","url":"https://pubmed.ncbi.nlm.nih.gov/25363495","citation_count":21,"is_preprint":false},{"pmid":"37544034","id":"PMC_37544034","title":"APE1 promotes radiation resistance against radiation-induced pyroptosis by inhibiting the STING pathway in lung adenocarcinoma.","date":"2023","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37544034","citation_count":21,"is_preprint":false},{"pmid":"39739423","id":"PMC_39739423","title":"Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models.","date":"2024","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/39739423","citation_count":20,"is_preprint":false},{"pmid":"18715142","id":"PMC_18715142","title":"APE1/Ref-1: versatility in progress.","date":"2009","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/18715142","citation_count":20,"is_preprint":false},{"pmid":"34115169","id":"PMC_34115169","title":"Characterization of APX and APX-R gene family in Brassica juncea and B. rapa for tolerance against abiotic stresses.","date":"2021","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34115169","citation_count":20,"is_preprint":false},{"pmid":"33675923","id":"PMC_33675923","title":"The APEX1/miRNA-27a-5p axis plays key roles in progression, metastasis and targeted chemotherapy of gastric cancer.","date":"2021","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/33675923","citation_count":20,"is_preprint":false},{"pmid":"19524065","id":"PMC_19524065","title":"HIF-1 attenuates Ref-1 expression in endothelial cells: reversal by siRNA and inhibition of geranylgeranylation.","date":"2009","source":"Vascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19524065","citation_count":20,"is_preprint":false},{"pmid":"31454981","id":"PMC_31454981","title":"Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma.","date":"2019","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/31454981","citation_count":19,"is_preprint":false},{"pmid":"35126448","id":"PMC_35126448","title":"Genome-Wide Identification and Analysis of the Ascorbate Peroxidase (APX) Gene Family of Winter Rapeseed (Brassica rapa L.) Under Abiotic Stress.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35126448","citation_count":19,"is_preprint":false},{"pmid":"34285771","id":"PMC_34285771","title":"Understanding APE1 cellular functions by the structural preference of exonuclease activities.","date":"2021","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/34285771","citation_count":19,"is_preprint":false},{"pmid":"28446640","id":"PMC_28446640","title":"Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.","date":"2017","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/28446640","citation_count":19,"is_preprint":false},{"pmid":"34703267","id":"PMC_34703267","title":"New Horizons for the Roles and Association of APE1/Ref-1 and ABCA1 in Atherosclerosis.","date":"2021","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/34703267","citation_count":18,"is_preprint":false},{"pmid":"32967121","id":"PMC_32967121","title":"Plasma APE1/Ref-1 Correlates with Atherosclerotic Inflammation in ApoE-/- Mice.","date":"2020","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/32967121","citation_count":18,"is_preprint":false},{"pmid":"33875645","id":"PMC_33875645","title":"LINC00470 accelerates the proliferation and metastasis of melanoma through promoting APEX1 expression.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33875645","citation_count":18,"is_preprint":false},{"pmid":"35780128","id":"PMC_35780128","title":"APEX1 regulates alternative splicing of key tumorigenesis genes in non-small-cell lung cancer.","date":"2022","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/35780128","citation_count":18,"is_preprint":false},{"pmid":"23370007","id":"PMC_23370007","title":"APE1/Ref-1 prevents oxidative inactivation of ERK for G1-to-S progression following lead acetate exposure.","date":"2013","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/23370007","citation_count":18,"is_preprint":false},{"pmid":"35311089","id":"PMC_35311089","title":"Potential Role of APEX1 During Ferroptosis.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35311089","citation_count":17,"is_preprint":false},{"pmid":"29292734","id":"PMC_29292734","title":"Elevation of Serum APE1/Ref-1 in Experimental Murine Myocarditis.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29292734","citation_count":17,"is_preprint":false},{"pmid":"33924520","id":"PMC_33924520","title":"Ascorbate Peroxidase Neofunctionalization at the Origin of APX-R and APX-L: Evidence from Basal Archaeplastida.","date":"2021","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33924520","citation_count":17,"is_preprint":false},{"pmid":"24861944","id":"PMC_24861944","title":"Mitochondrial APE1/Ref-1 suppressed protein kinase C-induced mitochondrial dysfunction in mouse endothelial cells.","date":"2014","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/24861944","citation_count":17,"is_preprint":false},{"pmid":"36512713","id":"PMC_36512713","title":"Genome-wide, evolutionary, and functional analyses of ascorbate peroxidase (APX) family in Poaceae species.","date":"2022","source":"Genetics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36512713","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50540,"output_tokens":8080,"usd":0.13641,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17645,"output_tokens":6119,"usd":0.1206,"stage2_stop_reason":"end_turn"},"total_usd":0.25701,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"The redox and DNA repair activities of APE1/Ref-1 are encoded by distinct, non-overlapping domains: the N-terminal domain (not conserved in other organisms) is required for redox activity, while conserved C-terminal sequences are required for DNA repair activity. Chemical alkylation or oxidation of cysteine sulfhydryls inhibits redox activity without affecting DNA repair activity. Crosslinking studies suggest a direct cysteine-mediated interaction between Ref-1 and Jun.\",\n      \"method\": \"Deletion mutagenesis, chemical alkylation/oxidation of cysteines, crosslinking assays, in vitro functional assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with deletion mutants and chemical mutagenesis, multiple orthogonal methods, widely replicated finding\",\n      \"pmids\": [\"7506414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"APE1/Ref-1 is a potent activator of p53 DNA-binding activity, acting by both redox-dependent and redox-independent mechanisms. Purified Ref-1 from HeLa nuclear extracts stimulates DNA binding by latent, oxidized p53. In the presence of reducing agent, Ref-1 stimulates full-length p53 but not the C-terminally truncated p53Δ30, indicating a redox-independent mechanism requiring the p53 C-terminus. Ref-1 also stimulates p53 transactivation in vivo.\",\n      \"method\": \"Protein purification from HeLa nuclear extracts, in vitro DNA-binding assays, in vivo transactivation assays, oxidized p53 stimulation assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical reconstitution with purified protein, multiple orthogonal methods (in vitro and in vivo), replicated in subsequent work\",\n      \"pmids\": [\"9119221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"APE1/Ref-1 stimulates the DNA-binding activity of the Pax-8 paired domain in vitro and enhances Pax-8-dependent transcriptional activation of the thyroglobulin promoter in co-transfection experiments, with nuclear Ref-1 levels correlating with reduced (active) Pax-8 levels in thyroid cell nuclear extracts.\",\n      \"method\": \"In vitro DNA-binding assay, co-transfection/reporter gene assay, immunoreactivity analysis of nuclear extracts\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — in vitro and cell-based assays from single lab, two orthogonal methods\",\n      \"pmids\": [\"9813166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Ref-1 associates physically with p53 in vivo and in vitro. Ref-1 overexpression enhances p53 transactivation of multiple target promoters (p21, cyclin G, Bax) and increases p53-induced apoptosis. Antisense-mediated downregulation of Ref-1 markedly reduces p53 induction of p21 mRNA/protein and p53 transactivation of p21 and Bax promoters.\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro), antisense knockdown, reporter gene assays, endogenous gene expression analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP in vivo and in vitro, antisense loss-of-function with defined phenotype, multiple target promoters tested\",\n      \"pmids\": [\"10523305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ERp57 (a protein disulfide isomerase) interacts with APE1/Ref-1 in vivo (by immunoprecipitation in HepG2, M14, and Raji cells). Oxidative stress increases nuclear Ref-1 associated with ERp57. ERp57 reduced by the thioredoxin-reductase/thioredoxin system stimulates AP-1 binding to DNA, and cells overexpressing ERp57 are protected against H2O2-induced cell killing, demonstrating cooperative activity between ERp57 and Ref-1 in reductive activation of transcription factors.\",\n      \"method\": \"Co-immunoprecipitation in multiple cell lines, DNA-binding assay, overexpression with oxidative stress challenge\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP in three cell lines, functional assay for cooperative activity, single lab\",\n      \"pmids\": [\"16962936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Both APE1 and APE2 function in immunoglobulin class switch recombination (CSR) in mice. Mice haploinsufficient for APE1 (and deficient in APE2) show reduced CSR and decreased double-strand breaks in switch regions, placing APE1 downstream of abasic site generation (by UNG) in the CSR pathway and demonstrating a novel in vivo function for APE1 in converting abasic sites to single-strand and double-strand breaks required for CSR.\",\n      \"method\": \"Genetic mouse models (haploinsufficiency, knockout), CSR assay, DSB measurement\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in vivo with defined mechanistic phenotype, epistasis placing APE1 in the CSR pathway\",\n      \"pmids\": [\"18025127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"APE1/Ref-1 regulates PTEN expression via Egr-1. Acetylation of APE1 enhances its binding to distinct trans-acting complexes involved in activation or repression of the PTEN promoter. The acetylated form is deacetylated by histone deacetylases in vivo. H2O2 and HDAC inhibitors increase APE1 acetylation and PTEN induction; this induction is absent in APE1-depleted cells. Acetylatable APE1 is required for PTEN gene activation.\",\n      \"method\": \"siRNA knockdown, overexpression, HDAC inhibitor treatment, promoter-reporter assay, co-immunoprecipitation\",\n      \"journal\": \"Free radical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple methods (KD, OE, inhibitors, reporter assays), single lab\",\n      \"pmids\": [\"18324520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"APE1 depletion by siRNA causes arrest of cell proliferation and apoptosis in human cell lines in culture, correlated with accumulation of unrepaired abasic DNA damage. All effects are reversed by expression of S. cerevisiae Apn1, which shares only the AP endonuclease repair function with Ape1, demonstrating that the essential cellular function of APE1 is its DNA repair (AP endonuclease) activity.\",\n      \"method\": \"RNA interference (siRNA), complementation with heterologous AP endonuclease (Apn1), cell proliferation and apoptosis assays, abasic site accumulation measurement\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic complementation with a repair-only enzyme identifies the essential activity, supported by biochemical readout of AP site accumulation\",\n      \"pmids\": [\"16199212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"STAT3 DNA-binding and transcriptional activity is directly regulated by the redox function of APE1/Ref-1. Pharmacological blockade of APE1/Ref-1 redox function with E3330 abrogates STAT3 DNA binding. A redox-specific APE1 mutant strategy and gene knockdown confirmed the redox-dependence of this regulation.\",\n      \"method\": \"Overexpression, redox-specific mutagenesis, siRNA knockdown, redox inhibitor (E3330) treatment, reporter gene/DNA-binding assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple orthogonal methods (mutagenesis, KD, small molecule), single lab\",\n      \"pmids\": [\"23094050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"APE1 has 3' RNA phosphatase and 3'-5' exoribonuclease activities that share the same active site as its DNA nuclease activities, as demonstrated by site-directed mutagenesis of active-site residues (H309N, H309S, D283N, N68A, D210N, Y171F, D308A, F266A, D70A) that abolish 3' RNA phosphatase activity. Several population variants including the common D148E variant show >80% reduction in 3' RNA phosphatase activity.\",\n      \"method\": \"In vitro RNA substrate assays, site-directed mutagenesis of active-site residues, functional characterization of population variants\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assay with systematic active-site mutagenesis, single lab but rigorous biochemical approach\",\n      \"pmids\": [\"25498387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"APE1/Ref-1 redox function negatively regulates NRF2: repression of Ref-1 (by genetic or small molecule inhibitor approaches) potently activates NRF2 and its downstream targets in a dose-dependent fashion. This effect requires the redox function, not the DNA repair function, of APE1, and does not involve reactive oxygen species.\",\n      \"method\": \"siRNA/shRNA knockdown, small molecule inhibitor (E3330), NRF2 reporter/target gene assays, genetic and pharmacological dissection of redox vs. repair functions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic and pharmacological methods to separate redox from repair function, single lab\",\n      \"pmids\": [\"25492865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"High-resolution crystal structures of human APE1 bound to DNA revealed: (1) the metal-binding site and nucleophile for AP-site incision; (2) arginine clamps that mediate product release; and (3) that a T-G mismatch 5' to the AP site is molded into a Watson-Crick-like geometry that distorts the active site and reduces incision efficiency, providing the molecular basis for clustered lesion processing.\",\n      \"method\": \"X-ray crystallography (multiple high-resolution APE1-DNA complex structures), kinetic/activity assays\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structures with multiple snapshots, functionally validated by activity assays\",\n      \"pmids\": [\"26458045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Endogenous APE1 protects against ischemic infarction in both gray and white matter. Conditional knockout of Apex1 in mice dramatically enlarges infarct volume, increases AP sites, and activates prodeath signaling (PUMA and PARP1) after focal cerebral ischemia. APE1 cKO also worsens demyelination and axonal conduction, demonstrating a role for endogenous APE1 in neurological recovery after stroke.\",\n      \"method\": \"Conditional knockout mouse (tamoxifen-inducible Cre), focal cerebral ischemia model, AP site measurement, γ-H2AX/PUMA/PARP1 signaling, behavioral/electrophysiological readouts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — first conditional knockout mouse for APE1 with multiple molecular and functional readouts in vivo\",\n      \"pmids\": [\"27274063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"APE1 variants D283G, L104R, and R237C have reduced AP endonuclease activity and impaired ability to associate with XRCC1 and DNA polymerase β (downstream BER partners), leading to persistent H2AX phosphorylation, elevated PAR protein levels, and growth defects through combined apoptotic and autophagic processes even without exogenous stress.\",\n      \"method\": \"shRNA silencing with variant complementation, Co-immunoprecipitation with XRCC1 and Pol β, γ-H2AX and PAR assays, cell growth analysis\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP for partner interactions, complementation assay, multiple molecular readouts, single lab\",\n      \"pmids\": [\"27050370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"APE1 facilitates BRCA1-mediated homologous recombination (HR) repair while counteracting error-prone non-homologous end joining of DNA double-strand breaks. APE1, coordinated with checkpoint kinase Chk2, regulates drug response of glioblastoma cells, and suppression of APE1/Chk2 signaling facilitates alternative HR protein recruitment.\",\n      \"method\": \"APE1 knockdown/overexpression, HR and NHEJ reporter assays, co-immunoprecipitation with Chk2 and HR proteins, glioblastoma cell drug response assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — functional reporter assays for HR/NHEJ choice, single lab with multiple methods\",\n      \"pmids\": [\"28852018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"High-resolution APE1-DNA crystal structures with 3' mismatches and DNA damage reveal that APE1 removes 3' mismatches and 3' damage by placing the 3' group within the intra-helical DNA cavity via a non-base-flipping mechanism. This process is facilitated by a DNA nick, instability of the mismatched/damaged base, and DNA bending by APE1.\",\n      \"method\": \"X-ray crystallography (multiple high-resolution APE1-DNA structural snapshots with mismatches/damage), biochemical activity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple high-resolution crystal structures with functional validation, rigorous structural and biochemical analysis\",\n      \"pmids\": [\"29374164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"APE1 deficiency (via shRNA in primary human fibroblasts) induces cellular senescence associated with global DNA damage accumulation, induction of p16INK4a and p21WAF1, and pronounced DNA damage response (γ-H2AX) particularly at telomeres. Conditional Apex1 knockout in post-natal mice causes impaired growth, reduced organ size, increased cellular senescence, and premature aging features. Telomerase expression prevents the senescence phenotype.\",\n      \"method\": \"shRNA knockdown in primary fibroblasts and telomerase-expressing cells, conditional knockout mouse, γ-H2AX/p16/p21 assays, telomere FISH\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — both cell-based and in vivo conditional KO with multiple molecular readouts, mechanistic dissection via telomerase rescue\",\n      \"pmids\": [\"29750271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"APE1 senses DNA single-strand breaks (SSBs) and initiates 3'-5' SSB end resection via its exonuclease activity. APE1's exonuclease activity is critical for both SSB repair and SSB signaling in Xenopus egg extracts and in vitro reconstitution. APE1 interacts with APE2 and PCNA (though PCNA is dispensable for APE1 exonuclease activity). An APE1 exonuclease-deficient mutant identified in cancer tissue lacks this SSB repair function.\",\n      \"method\": \"Xenopus egg extract system, in vitro reconstitution, exonuclease mutant analysis, Co-IP of APE1 with APE2 and PCNA\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro reconstitution and Xenopus system, mutagenesis, but single lab\",\n      \"pmids\": [\"31828326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"APE1 distinguishes DNA substrates in exonucleolytic cleavage by an induced space-filling mechanism. Binding dsDNA induces an RM (Arg176 and Met269) bridge that defines a long and narrow product pocket, providing substrate selectivity based on hydrophobicity and steric hindrance rather than base identity. Crystal structures of APE1-dsDNA complexes displaying end-binding were determined, and both endonucleolytic and exonucleolytic cleavage are explained by this induced space-filling model.\",\n      \"method\": \"X-ray crystallography of APE1-dsDNA end-binding complexes, enzymatic activity assays, binding affinity measurements for varied substrates\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures plus enzymatic and binding assays, mechanistic model validated with multiple substrates, single lab\",\n      \"pmids\": [\"33504804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Mitochondrial APE1 degrades dysfunctional (abasic) mitochondrial mRNA via endoribonuclease activity. Loss of APE1 results in accumulation of damaged mitochondrial mRNA, impaired mitochondrial protein translation, reduced expression of mitochondrial-encoded proteins, and less efficient mitochondrial respiration (oxidative phosphorylation).\",\n      \"method\": \"APE1 knockdown/depletion, mitochondrial mRNA association assays, endoribonuclease activity on abasic RNA, mitochondrial respiration (Seahorse), protein translation assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (RNA assay, respiration, translation), single lab\",\n      \"pmids\": [\"34224750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Oscillatory shear stress promotes acetylation of APE1 by acetyltransferase p300, leading to APE1 nuclear translocation. Nuclear APE1 promotes inflammation by orchestrating the NF-κB pathway. Endothelial-specific deletion of APEX1 ameliorates atherogenesis in a partial ligation mouse model, and overexpression of APEX1 negates the anti-inflammatory effect of vitexin.\",\n      \"method\": \"Co-immunoprecipitation of p300 with APEX1, siRNA knockdown, endothelial-specific APEX1 deletion (mouse), overexpression, NF-κB pathway analysis, carotid partial ligation model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo endothelial-specific KO, Co-IP for p300 interaction, multiple functional readouts, single lab\",\n      \"pmids\": [\"34810252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"APE1 assembles biomolecular condensates via its extreme N-terminal motif in nucleoli, recruits ATR and its activators TopBP1 and ETAA1, and directly activates ATR to phosphorylate Chk1 in vitro. This activity is independent of APE1 nuclease and redox functions. A W119R mutant is deficient in nucleolar condensation and cannot activate the nucleolar ATR DDR pathway or ATR kinase in vitro.\",\n      \"method\": \"APE1 overexpression/knockdown, biomolecular condensate assays in vitro and in cells, in vitro ATR kinase assay, nucleolar co-localization with NPM1, Co-IP with ATR/TopBP1/ETAA1, W119R mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay, mutagenesis, condensate assays, Co-IP; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"36200829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"APE1 cleaves solvent-exposed AP sites in nucleosomes with 3–6 orders of magnitude higher efficiency than occluded AP sites. A cryo-EM structure of APE1 bound to a nucleosome containing a solvent-exposed AP site reveals that APE1 uses a DNA sculpting mechanism, bending the nucleosomal DNA to access the AP site. Occluded AP sites are blocked by contacts between nucleosomal DNA and the histone octamer.\",\n      \"method\": \"Cryo-electron microscopy (APE1-nucleosome complex), kinetic AP site cleavage assays, biochemical analysis of nucleosomal substrates\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure combined with kinetic assays and biochemical characterization, rigorous mechanistic analysis\",\n      \"pmids\": [\"36104361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Secreted APE1/Ref-1, whose secretion is triggered by acetylation, inhibits TNF-α binding to TNFR1 by inducing a conformational change (thiol-disulfide exchange) in the TNF receptor 1. Recombinant APE1/Ref-1 with reducing activity induced conformational change in rh-TNFR1, and neutralizing anti-APE1 antibody reversed the anti-inflammatory effect, recovering ROS generation and VCAM-1 upregulation.\",\n      \"method\": \"Recombinant protein treatment, anti-APE1 neutralizing antibody, thiol-disulfide exchange assay with rh-TNFR1, VCAM-1/ROS measurement\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — biochemical interaction assay between APE1 and TNFR1, functional antibody neutralization, single lab\",\n      \"pmids\": [\"26964514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"APE1 redox activity prevents oxidative inactivation of ERK2, forming a direct complex with ERK2 and rescuing ERK kinase activity from ROS-induced inactivation. This effect is dependent on Cys65-mediated redox activity and facilitates Cyclin D1 expression and G1-to-S cell cycle progression after lead acetate exposure.\",\n      \"method\": \"Co-immunoprecipitation of APE1 with ERK2, siRNA knockdown, redox inhibitor (E3330), forced APE1 overexpression, ERK activity assays, cell cycle analysis\",\n      \"journal\": \"Toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, KD, and inhibitor approaches with defined mechanistic readout; single lab\",\n      \"pmids\": [\"23370007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Conditional deletion of Apex1 in T cells results in accumulation of abasic DNA sites in proliferating T cells, genomic instability, and apoptotic death, preventing acquisition of T effector features. Mutational analyses pinpointed the endonuclease domain as essential for T effector cell generation. Chemical inhibition of APE1 base repair activity similarly abrogated autoimmune disease induction in mouse models.\",\n      \"method\": \"Conditional knockout of Apex1 in T cells, mutational analysis of endonuclease domain, chemical inhibitors, autoimmune disease mouse models, abasic site quantification, apoptosis assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with domain-specific mutational dissection and pharmacological confirmation, multiple in vivo readouts\",\n      \"pmids\": [\"39739423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"APE1 inhibition promotes ferroptosis in hepatocellular carcinoma by activating AKT oxidation, impairing AKT phosphorylation/activation, which leads to GSK3β dephosphorylation/activation and ubiquitin-proteasome-dependent NRF2 degradation, thereby suppressing SLC7A11 and GPX4 expression and triggering lipid peroxidation. This pathway requires the redox activity of APE1.\",\n      \"method\": \"Genetic and chemical inhibition of APE1, AKT oxidation assay, GSK3β phosphorylation, NRF2 ubiquitination/degradation assay, SLC7A11/GPX4 expression, lipid peroxidation measurement\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical pathway assays, genetic and pharmacological methods, single lab\",\n      \"pmids\": [\"38418695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"APE1 controls DICER1 expression in non-small-cell lung cancer via regulation of miR-33a-5p and miR-130b-3p. DICER1 is validated as a direct functional target of APE1-regulated miRNAs, and IHC analyses confirmed a negative correlation between APE1 and DICER1 protein levels in human tumors.\",\n      \"method\": \"siRNA-mediated APE1 depletion, high-throughput miRNA profiling, miRNA target validation (DICER1 as target of miR-33a-5p and miR-130b-3p), IHC on human tumor tissue\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — functional target validation with knockdown and miRNA assays, IHC confirmation in human tissue, single lab\",\n      \"pmids\": [\"35876890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mitochondrial APE1/Ref-1 suppresses PKC-induced mitochondrial dysfunction (hyperpolarization and ROS generation) in mouse endothelial cells. PMA-induced PKC activation increases mitochondrial translocation of APE1/Ref-1, and a mitochondrial targeting sequence-fused APE1 more effectively suppresses mitochondrial dysfunction than wild-type APE1.\",\n      \"method\": \"PKC activator (PMA) treatment, APE1 overexpression and gene silencing, MTS-fused APE1 construct, mitochondrial membrane potential and ROS assays\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — overexpression/KD with functional readout, MTS fusion construct for compartment-specific rescue, single lab\",\n      \"pmids\": [\"24861944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"APE1 inhibits pyroptosis in lung adenocarcinoma cells by inactivating the STING pathway via direct interaction with AIM2 and DDX41 (as detected by co-immunoprecipitation). This interaction prevents STING pathway activation, contributing to radiation resistance.\",\n      \"method\": \"RNA-seq, co-immunoprecipitation (APE1 with AIM2 and DDX41), APE1 knockdown/overexpression, pyroptosis and STING pathway assays, radiation resistance assays\",\n      \"journal\": \"Translational oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP is single method, mechanistic link to STING inactivation via direct interaction established in one lab without independent validation\",\n      \"pmids\": [\"37544034\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"APE1/Ref-1 is a multifunctional enzyme whose C-terminal domain performs essential AP endonuclease activity in base excision repair (cleaving the DNA backbone 5' to abasic sites via a metal-dependent mechanism with arginine clamps and a DNA-sculpting mechanism that also operates in the nucleosome), while its N-terminal domain mediates redox-dependent reductive activation of multiple transcription factors (AP-1, p53, NF-κB, HIF-1α, STAT3, Pax-8 and others) through a cysteine-mediated mechanism; additional activities include 3'-5' exonuclease and 3' RNA phosphatase/exoribonuclease functions sharing the same catalytic active site, initiation of SSB end resection, participation in immunoglobulin class switch recombination, condensate-dependent activation of the ATR-Chk1 DDR pathway in nucleoli, and regulation of mitochondrial mRNA quality control, with the protein's subcellular localization and activity further modulated by post-translational modifications including acetylation (which drives nuclear translocation and secretion) and interactions with partners including p53, XRCC1, DNA polymerase β, ERK2, ERp57, and the p300 acetyltransferase.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"APE1/Ref-1 is a multifunctional enzyme that couples DNA base excision repair (BER) to redox-dependent regulation of transcription, with its two activities encoded by separable domains: a non-conserved N-terminal domain mediates cysteine-dependent reductive activation of transcription factors, while conserved C-terminal sequences carry out DNA repair [#0]. The DNA repair arm performs AP endonuclease incision 5' to abasic sites through a metal- and nucleophile-dependent mechanism, using arginine clamps for product release and molding mismatched bases into Watson-Crick-like geometry to discriminate clustered lesions [#11]; the same active site also supports 3' mismatch/damage removal by a non-base-flipping, DNA-bending mechanism and exonucleolytic cleavage governed by an induced space-filling RM bridge [#15, #18], and operates on nucleosomal substrates by sculpting and bending DNA to reach solvent-exposed abasic sites [#22]. This repair function is the essential cellular activity of APE1, as a repair-only heterologous AP endonuclease rescues the proliferation arrest and apoptosis caused by APE1 depletion [#7], and it acts through BER partners XRCC1 and DNA polymerase β [#13] while initiating SSB end resection via its exonuclease activity in concert with APE2 and PCNA [#17]. In parallel, the redox function reductively activates transcription factors including p53, Pax-8, AP-1 and STAT3, with p53 stimulated by both redox-dependent and redox-independent mechanisms via direct physical association [#1, #3, #8], and negatively regulates NRF2 independently of repair [#10]. APE1 has additional RNA-directed roles, possessing 3' RNA phosphatase and 3'-5' exoribonuclease activities at its shared catalytic site [#9] and degrading abasic mitochondrial mRNA to sustain mitochondrial translation and respiration [#19]. Beyond catalysis, an extreme N-terminal motif drives nucleolar condensate assembly that recruits and activates the ATR-Chk1 DNA damage response independently of nuclease and redox functions [#21]. APE1 localization and secretion are tuned by p300-mediated acetylation, which drives nuclear translocation and NF-κB-dependent inflammatory signaling [#20]; in vivo, endogenous APE1 protects against ischemic brain injury [#12], restrains cellular senescence and premature aging [#16], and is required for T effector cell generation and class switch recombination [#5, #25].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that APE1/Ref-1's redox and DNA repair activities are mechanistically and structurally separable, defining the gene as a bifunctional protein rather than a single-activity enzyme.\",\n      \"evidence\": \"Deletion mutagenesis, cysteine alkylation/oxidation, and crosslinking in vitro\",\n      \"pmids\": [\"7506414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve atomic basis of either activity\", \"Cysteine identity mediating redox activity not pinpointed\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed APE1/Ref-1 activates p53 by both redox-dependent and redox-independent routes, broadening its transcriptional regulatory scope beyond simple cysteine reduction.\",\n      \"evidence\": \"Purified Ref-1 with in vitro DNA-binding and in vivo transactivation assays\",\n      \"pmids\": [\"9119221\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of redox-independent p53 stimulation not defined\", \"Physiological stimulus context unaddressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrated a direct physical APE1-p53 interaction that is functionally required for p53 transactivation of target genes and apoptosis, linking redox regulation to a defined transcriptional program.\",\n      \"evidence\": \"Reciprocal Co-IP and antisense knockdown with promoter-reporter and endogenous gene readouts\",\n      \"pmids\": [\"10523305\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interaction interface not mapped\", \"Did not separate repair from redox contribution to p53 effects\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Extended the redox-coactivator role to Pax-8, showing APE1/Ref-1 reductively activates a tissue-specific transcription factor.\",\n      \"evidence\": \"In vitro DNA-binding and co-transfection reporter assays in thyroid cells\",\n      \"pmids\": [\"9813166\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab cell-based evidence\", \"Direct interaction not demonstrated by reciprocal methods\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified ERp57 as an APE1 partner and component of a reductive activation system, providing a source of reducing equivalents for transcription factor activation under oxidative stress.\",\n      \"evidence\": \"Co-IP in three cell lines plus DNA-binding and oxidative-stress survival assays\",\n      \"pmids\": [\"16962936\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Stoichiometry and direct electron-transfer mechanism unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Resolved which APE1 activity is essential by complementation, proving the AP endonuclease repair function—not redox—is required for cell viability.\",\n      \"evidence\": \"siRNA depletion rescued by repair-only S. cerevisiae Apn1, with abasic site quantification\",\n      \"pmids\": [\"16199212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address non-essential but physiologically important redox/RNA roles\", \"Cell-line context only\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed that APE1's DNA nuclease active site also performs 3' RNA phosphatase and exoribonuclease chemistry, and that common population variants impair this RNA activity.\",\n      \"evidence\": \"In vitro RNA substrate assays with systematic active-site mutagenesis and variant characterization\",\n      \"pmids\": [\"25498387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular RNA substrates not identified in this study\", \"Functional consequence of variant RNA defects in vivo unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined a redox-specific role for APE1 in negatively regulating the NRF2 antioxidant program, cleanly separated from repair and independent of ROS.\",\n      \"evidence\": \"Genetic and small-molecule (E3330) repression with NRF2 reporter/target assays\",\n      \"pmids\": [\"25492865\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular target of redox action on NRF2 pathway not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Added STAT3 to the set of transcription factors whose DNA binding requires APE1 redox function, reinforcing redox control of oncogenic signaling.\",\n      \"evidence\": \"Redox-specific mutagenesis, knockdown, and E3330 inhibition with DNA-binding/reporter assays\",\n      \"pmids\": [\"23094050\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct STAT3-APE1 contact not structurally defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Provided the first high-resolution structural basis for AP-site incision, defining the metal/nucleophile site, arginine product-release clamps, and the mechanism of clustered lesion discrimination.\",\n      \"evidence\": \"Multiple X-ray structures of APE1-DNA complexes with kinetic validation\",\n      \"pmids\": [\"26458045\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not capture exonuclease or RNA substrate states\", \"Nucleosomal context not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated an endogenous neuroprotective role for APE1 in vivo, linking its repair function to limiting AP-site accumulation and prodeath signaling after stroke.\",\n      \"evidence\": \"Tamoxifen-inducible conditional Apex1 knockout in a focal cerebral ischemia model\",\n      \"pmids\": [\"27274063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not isolate repair vs redox contributions to neuroprotection\", \"Cell-type-specific source of protection not fully resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected disease-associated APE1 variants to defective partner engagement, showing reduced AP endonuclease activity and impaired XRCC1/Pol β association drive genomic stress and growth defects.\",\n      \"evidence\": \"shRNA-variant complementation with Co-IP and γH2AX/PAR readouts\",\n      \"pmids\": [\"27050370\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether interaction loss is cause or consequence of activity loss unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Implicated APE1 in double-strand break repair pathway choice, favoring BRCA1-mediated HR over error-prone NHEJ and influencing chemoresistance.\",\n      \"evidence\": \"Knockdown/overexpression with HR/NHEJ reporters and Co-IP with Chk2 and HR proteins\",\n      \"pmids\": [\"28852018\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which APE1 biases pathway choice not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the structural mechanism for 3' mismatch/damage removal, showing APE1 places the 3' group intra-helically without base flipping, aided by DNA nicks and bending.\",\n      \"evidence\": \"Multiple high-resolution APE1-DNA crystal structures with biochemical assays\",\n      \"pmids\": [\"29374164\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular pathway recruiting this proofreading activity not established\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established APE1 as a guardian against senescence and aging, with deficiency causing telomere-associated DNA damage and premature aging features rescuable by telomerase.\",\n      \"evidence\": \"shRNA in primary fibroblasts plus conditional Apex1 knockout mice with telomere FISH\",\n      \"pmids\": [\"29750271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link between APE1 loss and telomere-specific damage incomplete\", \"Repair vs other activities not dissected\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed APE1 senses single-strand breaks and initiates 3'-5' end resection via its exonuclease activity, defining a role in SSB repair and signaling beyond simple incision.\",\n      \"evidence\": \"Xenopus egg extract and in vitro reconstitution with exonuclease mutant and Co-IP of APE2/PCNA\",\n      \"pmids\": [\"31828326\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of APE1 vs APE2 resection in human cells unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Provided a unifying structural model—an induced RM space-filling bridge—explaining how APE1 selects substrates for both endonucleolytic and exonucleolytic cleavage by sterics rather than base identity.\",\n      \"evidence\": \"X-ray structures of APE1-dsDNA end-binding complexes with activity and binding assays\",\n      \"pmids\": [\"33504804\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single lab\", \"In-cell relevance of end-binding mode not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Uncovered a mitochondrial RNA surveillance function, showing APE1 degrades abasic mitochondrial mRNA to maintain mitochondrial translation and respiration.\",\n      \"evidence\": \"APE1 depletion with endoribonuclease assays, Seahorse respiration, and translation readouts\",\n      \"pmids\": [\"34224750\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full set of mitochondrial RNA substrates not catalogued\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed a non-catalytic scaffolding function: APE1 forms nucleolar condensates that recruit and directly activate the ATR-Chk1 DDR pathway, independent of nuclease and redox activities.\",\n      \"evidence\": \"Condensate assays, in vitro ATR kinase assay, Co-IP with ATR/TopBP1/ETAA1, and W119R mutagenesis\",\n      \"pmids\": [\"36200829\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological trigger for nucleolar condensation unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended AP-site incision to chromatin, showing APE1 cleaves solvent-exposed nucleosomal abasic sites via a DNA-sculpting/bending mechanism while occluded sites are protected.\",\n      \"evidence\": \"Cryo-EM of an APE1-nucleosome complex with kinetic cleavage assays\",\n      \"pmids\": [\"36104361\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How occluded sites are eventually repaired not resolved\", \"Role of chromatin remodelers not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked acetylation-controlled APE1 trafficking to vascular inflammation, with p300-driven acetylation promoting nuclear translocation and NF-κB-dependent atherogenesis.\",\n      \"evidence\": \"Co-IP of p300/APEX1, endothelial-specific Apex1 deletion in a partial ligation mouse model\",\n      \"pmids\": [\"34810252\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Acetylated residues and NF-κB engagement mechanism not fully mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated the endonuclease repair function is required in vivo for adaptive immunity, with T-cell Apex1 loss causing abasic-site accumulation, genomic instability, and failed T effector generation.\",\n      \"evidence\": \"Conditional T-cell Apex1 knockout with domain-specific mutagenesis and chemical inhibition in autoimmune models\",\n      \"pmids\": [\"39739423\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Redox-domain contribution to T-cell function not isolated\", \"Substrate context driving the requirement not detailed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How APE1's multiple activities—repair, redox, RNA processing, and condensate scaffolding—are coordinately partitioned across nucleus, nucleolus, mitochondria, and the secreted pool in a single cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking PTM state to activity selection\", \"Quantitative partitioning between compartments unknown\", \"Crosstalk between redox and repair functions in vivo undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [7, 11, 15, 18, 22]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [9, 19]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [11, 15, 18, 17]},\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 24]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 3, 8]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [11, 15, 18]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [9, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 3, 20]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [19, 28]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [7, 11, 13, 17]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 3, 8]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [10, 26]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5, 25]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [21, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"TP53\", \"XRCC1\", \"POLB\", \"APEX2\", \"PCNA\", \"EP300\", \"MAPK1\", \"PDIA3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}